A double-blind controlled study of gabap
β
L. Averbuch-Heller; R. J. Tusa; L. Fuhry; K. G. Rottach; G. L. Ganser; W. Heide;
π
Article
π
1997
π
John Wiley and Sons
π
English
β 782 KB
## Abstract We conducted a doubleβblind crossover trial comparing gabapentin (up to 900 mg/day) to baclofen (up to 30 mg/day) as therapy for acquired nystagmus in 21 patients. We measured visual acuity and the nystagmus before, and at the end of, 2 weeks on each medication. For a group of 15 patien